Join to View Full Profile
4534 West Gate BlvdSte 113Austin, TX 78745
Phone+1 512-388-5717
Fax+1 512-366-9575
Dr. Lucksinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas at Austin Dell Medical SchoolResidency, Family Medicine, 1989 - 1992
The University of Texas Health Science Center at San AntonioClass of 1989
Certifications & Licensure
CO State Medical License 2021 - 2027
TX State Medical License 1990 - 2026
NM State Medical License 2025 - 2025
NV State Medical License 2018 - 2023
OR State Medical License 2020 - 2023
American Board of Family Medicine Family Medicine
Clinical Trials
- Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis Start of enrollment: 2013 Dec 01
- 12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
- Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Start of enrollment: 2014 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsImmunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trialMark Turner, Athanasia Papadimitriou, Peter Winkle, Nathan Segall, Michael Levin
Human Vaccines & Immunotherapeutics. 2020-03-02 - 27 citationsEffects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Control...Nicholas Van Wagoner, Kenneth H. Fife, Peter A. Leone, David I. Bernstein, Terri Warren
The Journal of Infectious Diseases. 2018-11-05 - 244 citationsEvaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13...Dan H. Barouch, Frank Tomaka, Frank Wegmann, Daniel J. Stieh, Galit Alter
Lancet. 2018-07-21
Journal Articles
- Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled TrialDavid I Bernstein, John Kriesel, William Koltun, Gregg Lucksinger, Peter A Leone, Richard Beigi, Stephen Tyring, Richard M Novak, Seth Hetherington, The Journal of Infectious Diseases
Press Mentions
The AMA Does Not Speak for UsDecember 9th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
